Jubilant Life Sciences gains on RBI approving FIIs to acquire up to 45% stake in company

21 Dec 2015 Evaluate

Jubilant Life Sciences is currently trading at Rs. 431.20, up by 12.00 points or 2.86% from its previous closing of Rs. 419.20 on the BSE.

The scrip opened at Rs. 426.00 and has touched a high and low of Rs. 436.00 and Rs. 426.00 respectively. So far 44,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 455.00 on 07-Dec-2015 and a 52 week low of Rs. 116.20 on 26-Dec-2014.

Last one week high and low of the scrip stood at Rs. 436.00 and Rs. 416.00 respectively. The current market cap of the company is Rs. 6,880.00 crore.

The promoters holding in the company stood at 54.02% while Institutions and Non-Institutions held 18.12% and 27.85% respectively.

Reserve Bank of India (RBI) has allowed foreign institutional investors (FIIs) and registered foreign portfolio investors (RFPI) to buy up to 45% stake in Jubilant Life Sciences under the portfolio investment scheme.

The company had earlier received approval from its Board and shareholders for hiking the limit of purchase of its equity shares and convertible debentures by FIIs/RFPIs, who can now buy these instruments through primary and secondary markets.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery Solutions.


Jubilant Pharmova Share Price

1141.20 10.35 (0.92%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.